Valeant Builds On Ophthalmic Device Biz With Synergetics Buy
This article was originally published in Clinica
Executive Summary
Valeant Pharmaceuticals International Inc. is building on its 2013-acquired ophthalmic surgical device portfolio with a purchase of Synergetics USA Inc.